It may help to increase the utilization of fatty acids as an energy source, which could contribute to weight loss efforts
This was the very question Tuell and colleagues set out to explore
While estrogen and cortisol are not standard lab tests for patients taking GLP-1 medications (unless the patient has pre-existing conditions like PCOS or an adrenal disorder or is exhibiting specific symptoms), there is a growing body of research that indicates the drugs can affect and interact with these hormones, especially in certain patient populations, like women navigating menopause
A critical aspect of FFOXO4-DRI's administration, especially given its experimental nature, is the vigilant tracking of vital biomarkers
Retinal Ischemia First, retinal ischemia as the final drawback [118,119,120,121] was likely to be resolved [11]